NCT07630974: A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 134 planned
- Started
- 6 Jul 2026
- Primary completion
- 17 Aug 2031
- Arms
- Ifinatamab Deruxtecan
- Results
- None posted
- 5 Jun 2026: Trial registered
- 6 Jul 2026: Trial started